Hypoglycemia: Clinical Trials

8 trials for Hypoglycemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 terminated. 8 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Terminated 8
Phase 23Terminated 3

Follow Hypoglycemia: new trials by email Literature Review of Hypoglycemia trials Research Report on Hypoglycemia

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus
ZT-01 low dose, ZT-01 high dose, Placebo - Type 1 Diabetes, Hypoglycemia
Phase 1TerminatedZucara Therapeutics Inc.242021-07-082023-07-12
Insulin Tolerance Test Study in Patients With Type 1 Diabetes
Pitolisant - Type 1 Diabetes, Hypoglycemia
Phase 1TerminatedHigh Point Clinical Trials Center52019-09-152021-04-02
Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia
intra-nasal naloxone, Intra-nasal saline - Hypoglycemia Unawareness, Type 1 Diabetes
Phase 1 / Phase 2TerminatedUniversity of Minnesota112016-06-012023-03-27
CREON for the Treatment of Post-RYGB Hypoglycemia
Creon, Diet, Placebo - Hypoglycemia
Phase 1TerminatedEast Carolina University52014-02-012023-10-26
Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery
Exendin (9-39), Placebo - Hypoglycemia
Phase 1TerminatedTracey McLaughlin102014-02-012024-12-04
Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia
Exendin (9-39), Vehicle - Congenital Hyperinsulinism
Phase 1 / Phase 2TerminatedDiva De Leon142009-08-262020-06-01
Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome
Cinnamon Supplementation, Placebo (wheat flour) - Polycystic Ovary Syndrome, Insulin Resistance
Phase 1TerminatedPennington Biomedical Research Center82009-08-012021-08-25
Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes
Allogeneic islets of Langerhans transplant, Raptiva, Sirolimus - Type 1 Diabetes Mellitus, Hypoglycemia
Phase 1 / Phase 2TerminatedUniversity of Minnesota232007-11-012017-10-25

Narrower conditions

Diabetes Mellitus, Type 1 (4)  ·  Congenital Hyperinsulinism (1)  ·  Diabetes Mellitus (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Infant, Newborn, Diseases (1)  ·  Insulin Resistance (1)  ·  Metabolic Diseases (1)  ·  Pancreatic Diseases (1)  ·  Polycystic Ovary Syndrome (1)

Broader conditions

Nutritional and Metabolic Diseases (8)  ·  Glucose Metabolism Disorders (7)  ·  Metabolic Diseases (7)  ·  Endocrine System Diseases (5)  ·  Autoimmune Diseases (4)  ·  Immune System Diseases (4)  ·  Diabetes Mellitus (3)  ·  Adnexal Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Cysts (1)  ·  Digestive System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)

Interventions

exendin (9-39) (2)  ·  Antilymphocyte Serum (1)  ·  Diet (1)  ·  Flour (1)  ·  Naloxone (1)  ·  Pancrelipase (1)  ·  Sirolimus (1)  ·  efalizumab (1)  ·  pitolisant (1)  ·  thymoglobulin (1)

Sponsors

University of Minnesota (2)  ·  Diva De Leon (1)  ·  East Carolina University (1)  ·  High Point Clinical Trials Center (1)  ·  Pennington Biomedical Research Center (1)  ·  Tracey McLaughlin (1)  ·  Zucara Therapeutics Inc. (1)

Countries

United States (6)  ·  Canada (1)

Top investigators

Amir Moheet, MD (1)  ·  Bernhard J. Hering, M.D. (1)  ·  Colleen Craig, M.D. (1)  ·  Diva D De Leon, MD MSCE (1)  ·  Leanne Redman, PhD (1)  ·  Melanie Fein, MD (1)  ·  Moahad S Dar, MD (1)  ·  Richard Liggins, PhD (1)

Results publications

PMID 27975209, PMID 42168649